Behov for større sikkerhed omkring medicin til børn og unge i Danmark

Anne-Cathrine Finnemann Viuff, Lene Bistrup, Pernille Mathiesen, Mia Ortved Bjerager, Tine Brink Henriksen

Publikation: Bidrag til tidsskriftReviewForskningpeer review

Abstrakt

Only 30% of medication used for children and adolescents and 10% of the medication used for neonates has been evaluated for use in these populations. Infants and children differ from adults regarding pharmacodynamic and -kinetics, but they also differ from each other due to e.g. age, weight, and body composition, as we argue in this review. There is only limited knowledge within this area leading to the use of off-label, extemporaneous and unlicensed medication. Greater national vigilance in medication for children and adolescent is warranted to secure better and safer medicine for newborns, infants, children and adolescents.

Bidragets oversatte titelGreater vigilance in medication for children and adolescent is warranted in Denmark
OriginalsprogDansk
ArtikelnummerV01200003
Antal sider7
TidsskriftUgeskrift for laeger
Vol/bind182
StatusUdgivet - 2 nov. 2020

Fingeraftryk Udforsk hvilke forskningsemner 'Behov for større sikkerhed omkring medicin til børn og unge i Danmark' indeholder.

Citationsformater